MediciNova: Vanguard Capital Management reports 7.2% stake
The disclosure distinguishes voting authority from disposition authority and identifies the Index Fund's interest as more than 5% of MediciNova's common-stock class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MediciNova Inc. (MNOV) is the issuer for which Vanguard Capital Management LLC and Vanguard Morningstar Total Stock Market Index Fund report beneficial ownership of common stock.
As of September 30, 2026, Vanguard Capital Management reported beneficial ownership of 3,548,731 shares (7.20%), sole voting power over 311,803 shares, and sole dispositive power over 3,548,731 shares. The Index Fund reported beneficial ownership of 2,644,974 shares (5.37%), sole voting power over 2,644,974 shares, and zero sole or shared dispositive power.
Vanguard Capital Management stated that it and the covered investment companies and managed accounts have rights to dividends or sale proceeds; the Index Fund's interest is identified as more than 5% of the class. My Trieu-Gatt signed as Authorized Signatory, Head of Global Fund Administration, and as Authorized Signatory, Treasurer.
Key Figures
Key Terms
beneficially owned regulatory
sole voting power regulatory
sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.